Epidemiological evidence relating snus to health – an updated review based on recent publications

Harm Reduction Journal

Peter N Lee¹ 

[1] P N Lee Statistics and Computing Ltd, Sutton, Surrey SM2 5DA, United Kingdom

关键词: Smokeless;    Tobacco;    Circulatory disease;    Oral disease;    Cancer;   

Others  :  809787
DOI  :  10.1186/1477-7517-10-36

 received in 2012-12-04, accepted in 2013-12-02,  发布年份 2013

【 摘 要 】

An earlier review summarized evidence relating use of snus (Swedish-type moist snuff) to health and to initiation and cessation of smoking. This update considers the effect recent publications on snus use and health have on the overall evidence. The additional evidence extends the list of neoplastic conditions unassociated with snus use (oropharynx, oesophagus, stomach, lung) to include colorectal cancer and acoustic neuroma, and further undermines the weakly-based argument that snus use increases the risk of pancreatic cancer, although there is a report of poorer cancer survival in users. It remains undemonstrated that “snuff-dipper’s lesion” increases risk of oral cancer, and recent publications add to the evidence that snus use has no effect on periodontitis or dental caries. Although onset of acute myocardial infarction is not adversely associated with snus use, there is some evidence of an association with reduced survival. Whether this is a direct effect of snus use or a result of confounding by socioeconomic status or other factors requires further investigation, as does a report of an increased risk of heart failure in snus users. Even if some adverse health effects of snus use do exist, it remains clear that they are far less than those of smoking.

【 授权许可】

   
2013 Lee; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Brunnemann KD, Hoffman D: Chapter 3. Carcinogenesis. Chemical composition of smokeless tobacco products. In Smokeless Tobacco or Health. An international perspective. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 1992:96-108. [Smoking and tobacco control. Monograph No. 2.] NIH Publication No. 92-3461
• [2]Brunnemann KD, Qi J, Hoffman D: Aging of Oral Moist Snuff and the Yields of Tobacco-Specific N-Nitrosamines (TSNA). American Health Foundation; 2001. [Progress Report]
• [3]International Agency for Research on Cancer: Smokeless Tobacco and Some Tobacco-Specific N-Nitrosamines. Volume 89. Lyon, France: IARC; 2007. (Accessed Oct 2010). [IARC Monographs on the evaluation of carcinogenic risks to humans.] http://monographs.iarc.fr/ENG/Monographs/vol89/mono89.pdf webcite
• [4]Weitkunat R, Sanders E, Lee PN: Meta-analysis of the relation between European and American smokeless tobacco and oral cancer. BMC Public Health 2007, 7:334. BioMed Central Full Text
• [5]Holm H, Jarvis MJ, Russell MAH, Feyerabend C: Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology (Berl) 1992, 108:507-511.
• [6]Bolinder G, Norén A, Wahren J, de Faire U: Long-term use of smokeless tobacco and physical performance in middle-aged men. Eur J Clin Invest 1997, 27:427-433.
• [7]Bolinder G, Norén A, de Faire U, Wahren J: Smokeless tobacco use and atherosclerosis: an ultrasonographic investigation of carotid intima media thickness in healthy middle-aged men. Atherosclerosis 1997, 132:95-103.
• [8]Bolinder G, de Faire U: Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users. Am J Hypertens 1998, 11:1153-1163.
• [9]Eliasson M, Lundblad D, Hägg E: Cardiovascular risk factors in young snuff-users and cigarette smokers. J Intern Med 1991, 230:17-22.
• [10]Agewall S, Persson B, Lindstedt G, Fagerberg B: Smoking and use of smokeless tobacco in treated hypertensive men at high coronary risk: utility of urinary cotinine determination. Br J Biomed Sci 2002, 59:145-149.
• [11]Wennmalm A, Benthin G, Granström EF, Persson L, Petersson A-S, Winell S: Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. Circulation 1991, 83:1698-1704.
• [12]Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR): Health Effects of Smokeless Tobacco Products. Brussels: European Commission, Health & Consumer Protection Directorate-General; 2008. (Accessed Oct 2010). http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_013.pdf webcite
• [13]Lee PN: Circulatory disease and smokeless tobacco in Western populations: a review of the evidence. Int J Epidemiol 2007, 36:789-804.
• [14]Kallischnigg G, Weitkunat R, Lee PN: Systematic review of the relation between smokeless tobacco and non-neoplastic oral diseases in Europe and the United States. BMC Oral Health 2008, 8:13. BioMed Central Full Text
• [15]Sponsiello-Wang Z, Weitkunat R, Lee PN: Systematic review of the relation between smokeless tobacco and cancer of the pancreas in Europe and North America. BMC Cancer 2008, 8:356. BioMed Central Full Text
• [16]Lee PN, Hamling JS: Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Med 2009, 7:36. BioMed Central Full Text
• [17]Lee PN: Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol 2011, 59:197-214.
• [18]Axéll T, Mörnstad H, Sundström B: The relation of the clinical picture to the histopathology of snuff dipper’s lesions in a Swedish population. J Oral Pathol 1976, 5:229-236.
• [19]Bertuccio P, La Vecchia C, Silverman DT, Petersen GM, Bracci PM, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham ET, Bamlet WR, Holly EA, Lucenteforte E, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Bosetti C, Boffetta P: Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the international pancreatic cancer case-control consortium (PanC4). Ann Oncol 2011, 22:1420-1426.
• [20]Hansson J, Galanti MR, Hergens M-P, Fredlund P, Ahlbom A, Alfredsson L, Bellocco R, Eriksson M, Hallqvist J, Hedblad B, Jansson J-H, Nilsson P, Pedersen N, Lagerros YT, Östergren P-O, Magnusson C: Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies. Eur J Epidemiol 2012, 27:771-779.
• [21]Hirsch JM, Wallström M, Carlsson A-P, Sand L: Oral cancer in Swedish snuff dippers. Anticancer Res 2012, 32:3327-3330.
• [22]Nordenvall C, Nilsson PJ, Ye W, Nyrén O: Smoking, snus use and risk of right- and left-sided colon, rectal and anal cancer: a 37 year follow-up study. Int J Cancer 2011, 128:157-165.
• [23]Nordenvall C, Nilsson PJ, Ye W, Andersson TML, Nyrén O: Tobacco use and cancer survival: a cohort study of 40,230 Swedish male construction workers with incident cancer. Int J Cancer 2013, 132:155-161.
• [24]Palmisano S, Schwartzbaum J, Prochazka M, Pettersson D, Bergenheim T, Florentzson R, Harder H, Mathiesen T, Nyberg G, Siesjö P, Feychting M: Role of tobacco use in the etiology of acoustic neuroma. Am J Epidemiol 2012, 175:1243-1251.
• [25]Arefalk G, Hergens M-P, Ingelsson E, Ärnlöv J, Michaëlsson K, Lind L, Ye W, Nyrén O, Lambe M, Sundström J: Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts. Eur J Prev Cardiol 2012, 19:1120-1127.
• [26]Hugoson A, Rolandsson M: Periodontal disease in relation to smoking and the use of Swedish snus: epidemiological studies covering 20 years (1983-2003). J Clin Periodontol 2011, 38:809-816.
• [27]Hugoson A, Hellqvist L, Rolandsson M, Birkhed D: Dental caries in relation to smoking and the use of Swedish snus: epidemiological studies covering 20 years (1983-2003). Acta Odontol Scand 2012, 70:289-296.
• [28]Luo J, Ye W, Zendehdel K, Adami J, Adami H-O, Boffetta P, Nyrén O: Oral use of Swedish moist snuff (snus) and risk of cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007, 369:2015-2020.
• [29]Boffetta P, Aagnes B, Weiderpass E, Andersen A: Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer 2005, 114:992-995.
• [30]Rutqvist LE, Lewin F: Flawed methods [Letter]. Int J Cancer 2006, 118:1581.
• [31]Nilsson R: Possible carcinogenicity of smokeless tobacco [Letter]. Int J Cancer 2006, 118:1582-1583.
• [32]Ramström L: Re: “smokeless tobacco use and risk of cancer of the pancreas and other organs” by boffetta et al [letter]. Int J Cancer 2006, 118:1584.
• [33]Rodu B, Cole P: A deficient study of smokeless tobacco use and cancer [Letter]. Int J Cancer 2006, 118:1585.
• [34]Nyrén O, Lambe M, Ye W, Adami H-O: Are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use? [Letter]. Ann Oncol 2011, 22:1930-1931.
• [35]Luo J, Iwasaki M, Inoue M, Sasazuki S, Otani T, Ye W, Tsugane S: Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan. The JPHC study. Cancer Causes Control 2007, 18:603-612.
• [36]Rodu B, Jansson C: Smokeless tobacco and oral cancer: a review of the risks and determinants. Crit Rev Oral Biol Med 2004, 15:252-263.
• [37]Roosaar A, Johansson ALV, Sandborgh-Englund G, Nyrén O, Axéll T: A long-term follow-up study on the natural course of snus-induced lesions among Swedish snus users. Int J Cancer 2006, 119:392-397.
• [38]Hergens M-P, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W: Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J Intern Med 2007, 262:351-359.
• [39]Janzon E, Hedblad B: Swedish snuff and incidence of cardiovascular disease. A population-based cohort study. BMC Cardiovasc Disord 2009, 9:21. BioMed Central Full Text
• [40]Hansson J, Pedersen NL, Galanti MR, Andersson T, Ahlbom A, Hallqvist J, Magnusson C: Use of snus and risk for cardiovascular disease: results from the Swedish twin registry. J Intern Med 2009, 265:717-724.
• [41]Bolinder G, Alfredsson L, Englund A, de Faire U: Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health 1994, 84:399-404.
• [42]Haglund B, Eliasson M, Stenbeck M, Rosén M: Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scand J Public Health 2007, 35:618-622.
• [43]Wennberg P, Eliasson M, Hallmans G, Johansson L, Boman K, Jansson J-H: The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J Intern Med 2007, 262:360-367.
• [44]Huhtasaari F, Asplund K, Lundberg V, Stegmayr B, Wester PO: Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? BMJ 1992, 305:1252-1256.
• [45]Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K: Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. J Am Coll Cardiol 1999, 34:1784-1790.
• [46]Hergens M-P, Ahlbom A, Andersson T, Pershagen G: Swedish moist snuff and myocardial infarction among men. Epidemiology 2005, 16:12-16.
• [47]Montén U, Wennström JL, Ramberg P: Periodontal conditions in male adolescents using smokeless tobacco (moist snuff). J Clin Periodontol 2006, 33:863-868.
• [48]Hirsch JM, Livian G, Edward S, Noren JG: Tobacco habits among teenagers in the city of Göteborg, Sweden, and possible association with dental caries. Swed Dent J 1991, 15:117-123.
• [49]Bergström J, Keilani H, Lundholm C, Rådestad U: Smokeless tobacco (snuff) use and periodontal bone loss. J Clin Periodontol 2006, 33:549-554.
• [50]Modéer T, Lavstedt S, Åhlund C: Relation between tobacco consumption and oral health in Swedish schoolchildren. Acta Odontol Scand 1980, 38:223-227.
• [51]Rolandsson M, Hellqvist L, Lindqvist L, Hugoson A: Effects of snuff on the oral health status of adolescent males: a comparative study. Oral Health Prev Dent 2005, 3:77-85.
• [52]Wickholm S, Söder P-Ö, Galanti MR, Söder B, Klinge B: Periodontal disease in a group of Swedish adult snuff and cigarette users. Acta Odontol Scand 2004, 62:333-338.
• [53]Boffetta P, Hecht S, Gray N, Gupta P, Straif K: Smokeless tobacco and cancer. Lancet Oncol 2008, 9:667-675.